Goldiam International Ltd has given multibagger returns of 547 in one year and an astounding 1278 returns in five years. The multibagger stock of 2021 has risen from Rs 151.95 to Rs 977.80 in the last one year, logging a

17,500 will act as key support while 18,000 will be strong resistance. Last week was one of the worst in recent times in terms of performance for the Indian equity market. Nifty 50 posted its worst weekly performance in the last eight months. It l

The benchmark index Nifty has lost 443 points or 2.44 in the last five trading sessions. The price action formed a sizeable bearish candle carrying lower high-lower low on the weekly chart. The weekly RSI has given bearish crossover and it is in fal

Shree Cement, the third-largest cement company in India, posted better-than-expected numbers for the second quarter ended September with both revenue and profit coming ahead of what analysts had forecast. The company’s standalone net profit rose

India sales increased 15.6 YoY at Rs. 24.2bn on core therapies growth but decreased 10.8 QoQ on account of lower COVID-19 sales. Cipla believes the broader Indian pharmaceuticals market (IPM) can sustain 10-12 annual sales growth without any obs

Bajaj Finance reported AUM growth of 22 YoY and 5 QoQ, 7-12 QoQ growth in consumer durables, personal loans, SME and rural segments, operating costs increased 76 YoY and 48 QoQ led by higher collection costs, increased manpower and branch additi

On Friday equity market closed on a volatile note. BSE Basic Material is the top gainer while the BSE Energy index is the top loser in today’s trade. In today’s trade Indian equity market was volatile, some sectoral indices closed up in green

ITC's 2QFY22 performance was driven by recovery in cigarette volumes and strong performance in the paperboard segment. Overall net sales stood at Rs. 1,27,310mn grew 13.8 YoY and 4.2 QoQ, PAT stood at Rs. 36,972mn, grew 14.4 YoY and 22.7 QoQ, and

Titan's robust margin expansion and earnings growth was driven by stellar sales performance along with the rate of expansion in EBIT margin across all its businesses in Q2FY22. Titan's total revenue excluding bullion segment sales grew by 76

L&T's 2QFY22 operational results were better than estimated, and the margins reported in both the segments were exceptional. Core business performance was affected by COVID challenges and uncertainties, however, margins fared better and wer

Dr Reddy’s Laboratories Ltd, one of the largest homegrown drugmakers, came up with strong results for the second quarter with double-digit growth in both revenue as well as profit. Dr Reddy’s consolidated net profit rose 30.2 to Rs 992 crore

Domestic benchmark indices ended the week on a weak note for the third consecutive day on October 29, 2021. The Indian markets closed in red for the third day in a row on Friday, dragged by banking and financial services shares. Index heavyweight